STLN
Starling Oncology, Inc.
NASDAQ · Healthcare · Medical - Care Facilities · US
$6.99
+5.43%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 77.00x
- P/S forward
- 0.93x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -28.59x
- Price / sales
- 1.21x
- Price / cash flow
- 2171.93x
Enterprise value
- Enterprise value
- $775.8M
- EV / sales
- 1.32x
- EV / EBITDA
- -35.50x
- EV / EBIT
- -29.73x
- Market cap
- $712.4M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026